Pyridyloxymethyl and benzisoxazole azabicyclic derivatives

Details for Australian Patent Application No. 2004220327 (hide)

Owner Pfizer Products Inc.

Inventors Brodney, Michael Aaron; Bright, Gene Michael; Wlodecki, Bishop

Agent Spruson & Ferguson

Pub. Number AU-B-2004220327

PCT Pub. Number WO2004/081007

Priority 60/453,925 12.03.03 US

Filing date 23 February 2004

Wipo publication date 23 September 2004

Acceptance publication date 24 June 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/00 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/081007 Priority application(s): WO2004/081007

24 June 2010 Application Accepted

  Published as AU-B-2004220327

21 October 2010 Standard Patent Sealed

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220338-2, 4DI (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

2004220325-Polypeptides